Citation Impact
Citing Papers
Lenalidomide in combination with melphalan and dexamethasone in patients with newly diagnosed AL amyloidosis: a multicenter phase 1/2 dose-escalation study
2010
Genome-wide CRISPR screens reveal a specific ligand for the glycan-binding immune checkpoint receptor Siglec-7
2021 StandoutNobel
Cyclophosphamide-bortezomib-dexamethasone (CyBorD) produces rapid and complete hematologic response in patients with AL amyloidosis
2012
Reconstituting Organ-Level Lung Functions on a Chip
2010 StandoutScience
Radioimmunodetection of amyloid deposits in patients with AL amyloidosis
2010
The involvement of calpain in the activation of protein kinase C in neutrophils stimulated by phorbol myristic acid.
1986
Efficacy of bortezomib in systemic AL amyloidosis with relapsed/refractory clonal disease
2008
Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance
2009 StandoutNature
Biochemical consequences of mechanical forces generated by distention and distortion
1989
Induction Therapy with Bortezomib Followed by Bortezomib-High Dose Melphalan and Stem Cell Transplantation for Light Chain Amyloidosis: Results of a Prospective Clinical Trial
2015
CD43, a molecule with multiple functions
1999
Monocyte chemotactic and activating factor is a potent histamine-releasing factor for basophils.
1992
Molecular identification of a renal urate–anion exchanger that regulates blood urate levels
2002 StandoutNature
Gout-associated uric acid crystals activate the NALP3 inflammasome
2006 StandoutNature
Review: Immunoglobulin Light Chain Amyloidosis—The Archetype of Structural and Pathogenic Variability
2000
Influence of Metabolism on Epigenetics and Disease
2013 StandoutNobel
Eprodisate for the Treatment of Renal Disease in AA Amyloidosis
2007
β-Arrestins regulate a Ral-GDS–Ral effector pathway that mediates cytoskeletal reorganization
2002
Chromatin Modifications and Their Function
2007 Standout
A phase II trial of cyclophosphamide, lenalidomide and dexamethasone in previously treated patients with AL amyloidosis
2012
Adverse Drug Reactions to Systemic Antifungals Prevention and Management
1992
Trends in day 100 and 2-year survival after auto-SCT for AL amyloidosis: outcomes before and after 2006
2010
Amyloid diseases of the heart: current and future therapies
2012
Molecular characterization of a peripheral receptor for cannabinoids
1993 StandoutNature
Consensus guidelines for the conduct and reporting of clinical trials in systemic light-chain amyloidosis
2012
Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis
2005
Diagnosis, Pathogenesis, Treatment, and Prognosis of Hereditary Fibrinogen Aα-Chain Amyloidosis
2008
Chemical Typing of Amyloid Protein Contained in Formalin-Fixed Paraffin-Embedded Biopsy Specimens
2001
Patients with immunoglobulin light chain amyloidosis undergoing autologous stem cell transplantation have superior outcomes compared with patients with multiple myeloma: a retrospective review from a tertiary referral center.
2013
CLIPs for organellemicrotubule interactions
1996
A Serpin Shapes the Extracellular Environment to Prevent Influenza A Virus Maturation
2015 StandoutNobel
Cellular Distribution and Functions of P2 Receptor Subtypes in Different Systems
2004
Inflammatory Mediators, Cytokines, and Adhesion Molecules in Pulmonary Inflammation and Injury
1996
Senile Systemic Amyloidosis Presenting With Heart Failure
2005
Longitudinal Left Ventricular Function for Prediction of Survival in Systemic Light-Chain Amyloidosis
2012
Structural Typing of Systemic Amyloidoses by Luminescent-Conjugated Polymer Spectroscopy
2009
Pannexin 1 channels mediate ‘find-me’ signal release and membrane permeability during apoptosis
2010 StandoutNature
Imaging cardiac amyloidosis: a pilot study using 18F-florbetapir positron emission tomography
2014
Antibody-Mediated Resolution of Light Chain-Associated Amyloid Deposits
2000
Systemic amyloidosis
2015 Standout
Update on colchicine and its mechanism of action
2002
High-Dose Melphalan versus Melphalan plus Dexamethasone for AL Amyloidosis
2007
Atherosclerosis — An Inflammatory Disease
1999 Standout
Association of melphalan and high-dose dexamethasone is effective and well tolerated in patients with AL (primary) amyloidosis who are ineligible for stem cell transplantation
2003
Bortezomib and dexamethasone consolidation following risk-adapted melphalan and stem cell transplantation for patients with newly diagnosed light-chain amyloidosis
2012
Membrane curvature and mechanisms of dynamic cell membrane remodelling
2005 StandoutNature
Antifungal and Surgical Treatment of Invasive Aspergillosis: Review of 2,121 Published Cases
1990 Standout
Points of control in inflammation
2002 StandoutNature
A matrix metalloproteinase expressed on the surface of invasive tumour cells
1994 StandoutNature
Evaluation and Management of the Cardiac Amyloidosis
2007
Molecular basis of sun-induced premature skin ageing and retinoid antagonism
1996 StandoutNature
Topographic diversity of fungal and bacterial communities in human skin
2013 StandoutNature
CLIP170-like tip1p Spatially Organizes Microtubular Dynamics in Fission Yeast
2000 StandoutNobel
Monogenic autoinflammatory diseases: new insights into clinical aspects and pathogenesis
2010
Molecular Mechanisms of Amyloidosis
2003 Standout
Granulocyte transfusion therapy for infections in candidates and recipients of HPC transplantation: a comparative analysis of feasibility and outcome for community donors versus related donors
2002
Nuclear ADP-Ribosylation Reactions in Mammalian Cells: Where Are We Today and Where Are We Going?
2006
The collagen substrate specificity of human skin fibroblast collagenase.
1981 Standout
Secretagogue-induced phosphoinositide metabolism in human leucocytes
1984
Diagnosis and Management of the Cardiac Amyloidoses
2005
Neutrophil Migration Mechanisms, with an Emphasis on the Pulmonary Vasculature
2000
Chemoattractants stimulate degradation of methylated phospholipids and release of arachidonic acid in rabbit leukocytes.
1979
Cloning and characterization of human tumor cell interstitial collagenase.
1990
Evidence for the Effects of a Superantigen in Rheumatoid Arthritis
1991 Science
Leukocyte lipid body formation and eicosanoid generation: cyclooxygenase-independent inhibition by aspirin.
1996 StandoutNobel
New Criteria for Response to Treatment in Immunoglobulin Light Chain Amyloidosis Based on Free Light Chain Measurement and Cardiac Biomarkers: Impact on Survival Outcomes
2012
Investigating Cell Surface Galectin-Mediated Cross-Linking on Glycoengineered Cells
2012 StandoutNobel
Bioregulation of lysosomal enzyme secretion from human neutrophils: roles of guanosine 3':5'-monophosphate and calcium in stimulus-secretion coupling.
1975 StandoutNobel
Safety and efficacy of risk-adapted cyclophosphamide, thalidomide, and dexamethasone in systemic AL amyloidosis
2006
Effect of phorbol 12-myristate 13-acetate and its analogue 4 alpha-phorbol 12,13-didecanoate on protein phosphorylation and lysosomal enzyme release in rabbit neutrophils.
1984
A phase 1/2 study of lenalidomide with low-dose oral cyclophosphamide and low-dose dexamethasone (RdC) in AL amyloidosis
2012
Integrins: Versatility, modulation, and signaling in cell adhesion
1992 Standout
Disorders of Phagocyte Function
1987
Pathogenesis of Foreign Body Infection: Description and Characteristics of an Animal Model
1982
Tissue injury in inflammation. Oxidants, proteinases, and cationic proteins.
1987
Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation: long-term results in a series of 421 patients
2011
Treatment with oral melphalan plus dexamethasone produces long-term remissions in AL amyloidosis
2007
Inositol trisphosphate, a novel second messenger in cellular signal transduction
1984 StandoutNature
Interactions Between the Microbiota and the Immune System
2012 StandoutScience
Bortezomib With or Without Dexamethasone in Primary Systemic (Light Chain) Amyloidosis
2010
Mechanotransduction Across the Cell Surface and Through the Cytoskeleton
1993 StandoutScience
Intracellular Signaling by Hydrolysis of Phospholipids and Activation of Protein Kinase C
1992 StandoutScience
Phase I/II trial of neutrophil transfusions from donors stimulated with G-CSF and dexamethasone for treatment of patients with infections in hematopoietic stem cell transplantation
2000
Current Trends in Diagnosis and Management of Cardiac Amyloidosis
2013
Chemotactic Factor Inactivation by the Myeloperoxidase-Hydrogen Peroxide-Halide System
1979
Pathogenesis of foreign body infection. Evidence for a local granulocyte defect.
1984
A genome-wide analysis of immune responses in Drosophila
2001 StandoutNobel
Molecular and Cellular Mechanisms of Leukocyte Chemotaxis
1981 Science
Serum Cardiac Troponins and N-Terminal Pro-Brain Natriuretic Peptide: A Staging System for Primary Systemic Amyloidosis
2004
Activation and differentiation requirements of primary T cells in vitro.
1993 StandoutNobel
Dose-intensive melphalan with blood stem cell support for the treatment of AL amyloidosis: one-year follow-up in five patients
1996
Efficacy and safety of once-weekly and twice-weekly bortezomib in patients with relapsed systemic AL amyloidosis: results of a phase 1/2 study
2011
The role of protein kinase C in cell surface signal transduction and tumour promotion
1984 StandoutNature
The HL-60 promyelocytic leukemia cell line: proliferation, differentiation, and cellular oncogene expression
1987
Innate Defense against Influenza A Virus: Activity of Human Neutrophil Defensins and Interactions of Defensins with Surfactant Protein D
2006
Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2
1997 StandoutNobel
Biochemical and immunological characterization of the secreted forms of human neutrophil gelatinase.
1985
Breakdown and synthesis of polyphosphoinositides in fMetLeuPhe‐stimulated neutrophils
1985
Phase I/II trial of neutrophil transfusions from donors stimulated with G-CSF and dexamethasone for treatment of patients with infections in hematopoietic stem cell transplantation
2000
Efficacy of transfusion with granulocytes from G-CSF/dexamethasone–treated donors in neutropenic patients with infection
2015
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
The tropism of organ involvement in primary systemic amyloidosis: contributions of Ig VL germ line gene use and clonal plasma cell burden
2001
Biomaterial-Centered Infection: Microbial Adhesion Versus Tissue Integration
1987 StandoutScience
Autologous stem cell transplantation for primary systemic amyloidosis
2002
Granules of the Human Neutrophilic Polymorphonuclear Leukocyte
1997 Standout
Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia
1982
Estradiol attenuates directed migration of vascular smooth muscle cells in vitro.
1996
Active Oxygen Species in the Induction of Plant Systemic Acquired Resistance by Salicylic Acid
1993 StandoutScience
A staging system for renal outcome and early markers of renal response to chemotherapy in AL amyloidosis
2014
Human galectin-1 recognition of poly-N-acetyllactosamine and chimeric polysaccharides
2003
Hormonal Control of Lysosomal Enzyme Release from Human Neutrophils: Elevation of Cyclic Nucleotide Levels by Autonomic Neurohormones
1974 StandoutNobel
Is Cytosolic Ionized Calcium Regulating Neutrophil Activation?
1983 StandoutScienceNobel
Studies and Perspectives of Protein Kinase C
1986 StandoutScience
Albumin inhibits neutrophil spreading and hydrogen peroxide release by blocking the shedding of CD43 (sialophorin, leukosialin)
1993
Tropism of sheep lentiviruses for monocytes: susceptibility to infection and virus gene expression increase during maturation of monocytes to macrophages
1986
A European collaborative study of treatment outcomes in 346 patients with cardiac stage III AL amyloidosis
2013
Aromatic Sulfonyl Fluorides Covalently Kinetically Stabilize Transthyretin to Prevent Amyloidogenesis while Affording a Fluorescent Conjugate
2013 StandoutNobel
Receptor class desensitization of leukocyte chemoattractant receptors.
1991
Hyperdiploidy is less frequent in AL amyloidosis compared with monoclonal gammopathy of undetermined significance and inversely associated with translocation t(11;14)
2011
Neutrophil Extracellular Traps Kill Bacteria
2004 StandoutScience
The role of chemical mediators in the pathogenesis of inflammation with emphasis on the kinin system
1990
Reappraisal of the pathogenesis and consequences of hyperuricemia in hypertension, cardiovascular disease, and renal disease
1999
Weekly and twice-weekly bortezomib in patients with systemic AL amyloidosis: results of a phase 1 dose-escalation study
2009
Antagonism of Catecholamine Receptor Signaling by Expression of Cytoplasmic Domains of the Receptors
1993 StandoutScienceNobel
Hormonal Control of Neutrophil Lysosomal Enzyme Release: Effect of Epinephrine on Adenosine 3′,5′-Monophosphate
1974 StandoutScienceNobel
HORMONAL CONTROL OF LYSOSOMAL ENZYME RELEASE FROM HUMAN NEUTROPHILS
1974 StandoutNobel
Structure and function of the leukocyte adhesion molecules CD11/CD18
1990
Glycogen accumulation in polymorphonuclear leukocytes, and other intracellular alterations that occur during inflammation.
1982
Detection of AIDS Virus in Macrophages in Brain Tissue from AIDS Patients with Encephalopathy
1986 StandoutScience
Movement of membrane tubules along microtubules in vitro: evidence for specialised sites of motor attachment
1994
Therapeutic potential of chimeric amyloid-reactive monoclonal antibody 11-1F4.
2003
Inhibition of receptor-mediated release of arachidonic acid by pertussis toxin
1984 StandoutNobel
Neutral Protease Release from Human Leukocytes regulated by Neurohormones and Cyclic Nucleotides
1973 StandoutNobel
Leukotriene B4 — a stereospecific stimulator for release of lysosomal enzymes from neutrophils
1981 StandoutNobel
Nonphagocytic release of neutral protease and β‐glucuronidase from human neutrophils regulation by autonomic neurohormones and cyclic neucleotides
1974 StandoutNobel
Lenalidomide, cyclophosphamide, and dexamethasone (CRd) for light-chain amyloidosis: long-term results from a phase 2 trial
2012
In vitro studies on the mode of action of the phorbol esters, potent tumor promoters: Part 1
1980
Transduction of Receptor Signals by ß-Arrestins
2005 StandoutScienceNobel
Estrogen inhibits the vascular injury response in estrogen receptor β-deficient female mice
1999 StandoutNobel
The activity of lenalidomide with or without dexamethasone in patients with primary systemic amyloidosis
2006
Works of Daniel G. Wright being referenced
[44] Human neutrophil degranulation
1988
Serum free light-chain responses after high-dose intravenous melphalan and autologous stem cell transplantation for AL (primary) amyloidosis
2005
High-dose intravenous melphalan and autologous stem cell transplantation as initial therapy or following two cycles of oral chemotherapy for the treatment of AL amyloidosis: results of a prospective randomized trial
2003
Low‐dose continuous oral melphalan for the treatment of primary systemic (AL) amyloidosis
2002
Modulation of the inflammatory response by products released from human polymorphonuclear leukocytes during phagocytosis
1975
Tandem cycles of high-dose melphalan and autologous stem cell transplantation increases the response rate in AL amyloidosis
2007
Collection of mobilized blood progenitor cells for hematopoietic rescue by large‐volume leukapheresis
1995
Mobilization of sialidase from intracellular stores to the surface of human neutrophils and its role in stimulated adhesion responses of these cells.
1991
Acquired Disorders of Phagocyte Function Complicating Medical and Surgical Illnesses
2001
AL amyloidosis associated with B‐cell lymphoproliferative disorders: Frequency and treatment outcomes
2006
Tolerability and Efficacy of Thalidomide for the Treatment of Patients with Light Chain–Associated (AL) Amyloidosis
2003
Guanine Ribonucleotide Metabolism and the Regulation of Myelopoiesis
1991
Lenalidomide and dexamethasone in the treatment of AL amyloidosis: results of a phase 2 trial
2006
Human Blood Monocytes: Characterization of Negatively Selected Human Monocytes and Their Suspension Cell Culture Derivatives
1981
Mobilization and extracellular release of granular enzymes from human leukocytes during phagocytosis: inhibition by colchicine and cortisol but not by salicylate
1973
Efficacy of Intermittent Colchicine Therapy in Familial Mediterranean Fever
1977
Interactions of cytoplasmic granules with microtubules in human neutrophils.
1989
Lethal Pulmonary Reactions Associated with the Combined Use of Amphotericin B and Leukocyte Transfusions
1981
Human neutrophil elastase functions as a type III collagen “Collagenase”
1980
INDUCTION OF PLASMINOGEN ACTIVATOR AND PLASMINOGEN ACTIVATOR INHIBITOR ACTIVITY DURING DIFFERENTIATION OF HL-60 CELLS
1987
High-Dose Melphalan and Autologous Stem-Cell Transplantation in Patients with AL Amyloidosis: An 8-Year Study
2004
Development of chemotactic responsiveness in myeloid precursor cells: studies with a human leukemia cell line.
1980
The differential mobilization of human neutrophil granules. Effects of phorbol myristate acetate and ionophore A23187.
1977
ATP induces transient elevations of [Ca2+]i in human neutrophils and primes these cells for enhanced O2- generation.
1988
Maturation of human promyelocytic leukemia cells induced by nicotinamide: Evidence of a regulatory role for ADP‐ribosylation of chromosomal proteins
1984
Dose-Intensive Melphalan With Blood Stem-Cell Support for the Treatment of AL (Amyloid Light-Chain) Amyloidosis: Survival and Responses in 25 Patients
1998
Effect of Dose-Intensive Intravenous Melphalan and Autologous Blood Stem-Cell Transplantation on AL Amyloidosis–Associated Renal Disease
2001
Improvement in quality of life of patients with AL amyloidosis treated with high-dose melphalan and autologous stem cell transplantation
2004
Characterization of influenza A virus binding sites on human neutrophils.
1994
Lymphocyte depletion by continuous flow cell centrifugation in rheumatoid arthritis
1979
Dose-Intensive Melphalan With Blood Stem-Cell Support for the Treatment of AL (Amyloid Light-Chain) Amyloidosis: Survival and Responses in 25 Patients
1998
Neutrophil-mediated endothelial injury in vitro mechanisms of cell detachment.
1981
A Functional Differentiation of Human Neutrophil Granules: Generation of C5a by a Specific (Secondary) Granule Product and Inactivation of C5a by Azurophil (Primary) Granule Products
1977
Role of secretory events in modulating human neutrophil chemotaxis.
1978
THE MOBILIZATION AND EXTRACELLULAR RELEASE OF GRANULAR ENZYMES FROM HUMAN LEUKOCYTES DURING PHAGOCYTOSIS
1972
Secretory Responses of Human Neutrophils: Exocytosis of Specific (Secondary) Granules by Human Neutrophils during Adherence in vitro and during Exudation in vivo
1979